Publicaciones en colaboración con investigadores/as de National University of Singapore (4)

2020

  1. Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myeloma

    Leukemia, Vol. 34, Núm. 11, pp. 3019-3027

2017

  1. Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: A multicenter IMWG study

    Leukemia, Vol. 31, Núm. 11, pp. 2443-2448

2016

  1. Treatment of multiple myeloma with high-risk cytogenetics: A consensus of the International Myeloma Working Group

    Blood, Vol. 127, Núm. 24, pp. 2955-2962

2014

  1. New drugs and novel mechanisms of action in multiple myeloma in 2013: A report from the International Myeloma Working Group (IMWG)

    Leukemia, Vol. 28, Núm. 3, pp. 525-542